International knowledge centre for information resources on leprosy

Printer-friendly versionSend by email

What's New?

  1. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.

    Nahas AA, Lima MIS, Goulart IMB, Goulart LR. Frontiers in immunology. 2018; 91205.
    Download PDF
  2. VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy.

    Fletcher HA, Chatterjee M, Cooper A, Hussell T, Kaye PM, Prior J, Reljic R, Vermaak S, Vordermeier M, Williams A, McShane H. F1000Research. 2018; 7485.
    Download PDF
  3. Leprosy-associated chronic wound management using biomaterials.

    Sivasubramanian S, Mohana S, Maheswari P, Victoria V, Thangam R, Mahalingam J, Chandrasekar-Janebjer G, Savariar V, Madhan B, Gunasekaran P, Kitambi SS. Journal of global infectious diseases. 2018; 10(2):99-107.
    Download PDF
  4. Autophagy impairment is associated with increased inflammasome activation and reversal reaction development in multibacillary leprosy.

    Mattos Barbosa MG, Andrade Silva BJ, Assis TQ, Silva Prata RB, Ferreira H, Andrade PR, Paixão de Oliveira JA, Sperandio da Silva GM, Costa Nery JA, Sarno EN, Pinheiro RO. Frontiers in immunology. 2018; 91223.
    Download PDF
  5. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.

    Cruz RCS, Bührer-Sékula S, Penna GO, Moraes MEA, Gonçalves HSá, Stefani MMA, Penna MLF, Pontes MAA, Talhari S. Anais brasileiros de dermatologia. 2018; 93(3):377-384.
    Download PDF

Sponsors & Partners